Image 2021 10 06 T14 17 55

Insights

Back to Insights
Blog Img

Jonas Skjødt Møller & Gregor Kawaletz, CEO and CCO of Albumedix - Mantell Associates Network Podcast

Episode 15 of this series of the Mantell Associates Network welcomes Jonas Skjødt Møller, CEO & Gregor Kawaletz, CCO at Albumedix.

In this episode Alessandro Mantell speaks with Jonas Skjødt Møller & Gregor Kawaletz. They cover everything from adapting to life and business during the COVID-19 pandemic, the importance of flexibility and agility as a business at this time, the secrets to good leadership and leading by example, and the exciting changes they see coming in the Pharmaceutical and Biopharmaceutical market.

Albumedixis a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilising albumin-based drug enhancing technologies. They partner with excellence to improve therapies for people with serious diseases, and are proud to be recognised as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with ~100 people all committed to improving patient quality of life.

You can also listen to this podcast on the following streams:

Mantell Associates is a specialist Pharmaceutical and Life Sciences Recruitment organisation. To find out how we can help with your headhunting or recruitment needs, or if joining us on the podcast and sharing your experience with the rest of the Pharmaceutical & Life Science industry is something you’d be interested in doing, please contact Alessandro Mantell on +44 (0)20 3778 0990 or alessandro@mantellassociates.com.